Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001415889-24-023132

CFO AND TREASURER sold 7,802 shares at $345.41 ($2,694,889)

  • CFO AND TREASURER acquired 8,332 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-09 Exercise or conversion : show line 1 in the form 10b5-1 +3,266 $120.26 $392,769 6,476 D
2024-09-09 Sale : show line 2 in the form 10b5-1 −3,266 $345.41 $1,128,109 3,210 D
2024-09-09 Exercise or conversion : show line 3 in the form 10b5-1 +3,400 $117.76 $400,384 6,610 D
2024-09-09 Sale : show line 4 in the form 10b5-1 −3,400 $345.41 $1,174,394 3,210 D
2024-09-09 Exercise or conversion : show line 5 in the form 10b5-1 +816 $120.26 $98,132 4,026 D
2024-09-09 Sale : show line 6 in the form 10b5-1 −558 $345.41 $192,739 3,468 D
2024-09-09 Exercise or conversion : show line 7 in the form 10b5-1 +850 $117.76 $100,096 4,318 D
2024-09-09 Sale : show line 8 in the form 10b5-1 −578 $345.41 $199,647 3,740 D
Open-market sales · 7,802 sh · avg $345.41 · $2,694,889

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-09-09 Exercise or conversion : show line 9 in the form 10b5-1 Stock Options −3,266 $120.26 2026-03-15 3,266 33,488 D
2024-09-09 Exercise or conversion : show line 10 in the form 10b5-1 Stock Options −3,400 $117.76 2027-03-15 3,400 146,350 D
2024-09-09 Exercise or conversion : show line 11 in the form 10b5-1 Stock Options −816 $120.26 2026-03-15 816 32,672 D
2024-09-09 Exercise or conversion : show line 12 in the form 10b5-1 Stock Options −850 $117.76 2027-03-15 850 145,500 D
Loading xslF345X05/form4-09102024_040902.xml…